Real-world (rw) outcomes to chemoimmunotherapy and biomarker analysis in extensive-stage small cell lung cancer (ES SCLC)

被引：0
|
作者：
Panagiotou, E. [1 ]
Livanou, M. E. [1 ]
Montgomery, A. [2 ]
Mastrogeorgiou, M. [1 ]
Moeckel, C. [2 ]
Syrigos, N. [1 ]
Mouratidis, I. [2 ]
Charpidou, A. [1 ]
Georgakopoulos-Soares, I. [2 ]
Vathiotis, I. [1 ]
机构：
[1] Sotiria Thorac Dis Hosp Athens, Med Oncol, Athens, Greece
[2] Penn State Coll Med, Biochem & Mol Biol, Hershey, PA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1238
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2007P
引用
收藏
页码：S1069 / S1069
页数：1
相关论文
共 50 条
  • [41] Phase 2 Study Analysis of Talazoparib (TALA) Plus Temozolomide (TMZ) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
    Goldman, J.
    Cummings, A.
    Mendenhall, M.
    Velez, M. A.
    Babu, S.
    Johnson, T.
    Alcantar, J.
    Dakhil, S.
    Kanamori, D.
    Lawler, W.
    Anand, S.
    Chauv, J.
    Garon, E.
    Slamon, D.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S32 - S32
  • [42] Prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer (ES-SCLC): A tertiary cancer centre experience
    Srivastava, A.
    Shelly, K.
    Lin, F.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S46 - S47
  • [43] Real-world treatment patterns, clinical outcomes, and health care resource utilization in extensive-stage small cell lung cancer in Canada.
    O'Sullivan, Dylan E.
    Brenner, Darren
    Syed, Iqra
    Shanahan, Mary Kate
    Moldaver, Daniel
    Sit, Christina
    Bebb, D. Gwyn
    Cheung, Winson Y.
    Boyne, Devon J.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Chemoimmunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) in patients with an Eastern Cooperative Group (ECOG) performance status (PS) of two or greater.
    Almquist, Daniel
    Langlais, Blake
    Yu, Nathan Y.
    Sio, Terence Tai Weng
    Savvides, Panos
    Yang, Ping
    Schild, Steven E.
    Mansfield, Aaron Scott
    Ernani, Vinicius
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility
    Fujimoto, Daichi
    Morimoto, Takeshi
    Tamiya, Motohiro
    Hata, Akito
    Matsumoto, Hirotaka
    Nakamura, Atsushi
    Yokoyama, Toshihide
    Taniguchi, Yoshihiko
    Uchida, Junji
    Sato, Yuki
    Yokoi, Takashi
    Tanaka, Hisashi
    Furuya, Naoki
    Masuda, Takeshi
    Sakata, Yoshihiko
    Miyauchi, Eisaku
    Hara, Satoshi
    Saito, Go
    Miura, Satoru
    Kanazu, Masaki
    Yamamoto, Nobuyuki
    Akamatsu, Hiroaki
    JAMA NETWORK OPEN, 2023, 6 (02) : E230698
  • [46] Ifinatamab Deruxtecan (I-DXd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Interim Analysis of Ideate-lung01
    Rudin, C. M.
    Ahn, M. -J.
    Johnson, M.
    Hann, C. L.
    Girard, N.
    Nishio, M.
    Cheng, Y.
    Hayashi, H.
    Kim, Y. Jung
    Navarro, A.
    Chen, Y.
    Sakai, T.
    Qian, M.
    Godard, J.
    Tang, M.
    Singh, J.
    Paz-Ares, L.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S15 - S16
  • [47] Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy
    Valette, Clarisse Audigier
    Filleron, Thomas
    Debieuvre, Didier
    Lena, Herve
    Perol, Maurice
    Chouaid, Christos
    Simon, Gaetane
    Quantin, Xavier
    Girard, Nicolas
    RESPIRATORY MEDICINE AND RESEARCH, 2023, 84
  • [48] Circulating tumor cells (CTC) as a biomarker of response in patients with extensive-stage small cell lung cancer (EX-SCLC).
    Huang, Chao H.
    Ganti, Apar Kishor
    Neupane, Prakash
    Sittampalam, G. Sitta
    Schmitt, Sarah
    Nirmalanandhan, Sanjit
    Williamson, Stephen K.
    Wick, Jo
    Smart, Janie
    Spencer, Sarah Ellen
    Godwin, Andrew K.
    Van Veldhuizen, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Real-world comparison of chemo-immunotherapy and chemotherapy alone in the treatment of extensive-stage small-cell lung cancer
    Lamy, Deborah
    Mouillot, Pierre
    Mariet, Anne-Sophie
    Barnestein, Robby
    Quilot, Fleur-Marie
    Fraisse, Clea
    Ghiringhelli, Francois
    Bonniaud, Philippe
    Zouak, Ayoube
    Foucher, Pascal
    RESPIRATORY MEDICINE AND RESEARCH, 2024, 86
  • [50] Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer
    Rittberg, Rebekah
    Leung, Bonnie
    Al-Hashami, Zamzam
    Ho, Cheryl
    FRONTIERS IN ONCOLOGY, 2022, 12
12345